Literature DB >> 6821102

A laboratory-acquired infection with Neisseria meningitidis.

A R Bhatti, V L DiNinno, F E Ashton, L A White.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6821102     DOI: 10.1016/s0163-4453(82)92563-4

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  5 in total

Review 1.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Structural and antigenic analysis of meningococcal piliation.

Authors:  R W Olafson; P J McCarthy; A R Bhatti; J S Dooley; J E Heckels; T J Trust
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

Review 3.  Assessing the risk of laboratory-acquired meningococcal disease.

Authors:  James J Sejvar; David Johnson; Tanja Popovic; J Michael Miller; Frances Downes; Patricia Somsel; Robbin Weyant; David S Stephens; Bradley A Perkins; Nancy E Rosenstein
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Enzyme electrophoresis, sero- and subtyping, and outer membrane protein characterization of two Neisseria meningitidis strains involved in laboratory-acquired infections.

Authors:  M Guibourdenche; J P Darchis; A Boisivon; E Collatz; J Y Riou
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

5.  Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccine.

Authors:  Jamie Findlow; Helen Findlow; Sarah Frankland; Ann Holland; Daniel Holme; Emma Newton; Jo Southern; Pauline Waight; Ed Kaczmarski; Elizabeth Miller; Ray Borrow
Journal:  J Occup Med Toxicol       Date:  2014-07-16       Impact factor: 2.646

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.